This inventor holds 1 USPTO granted patent. Top assignees: Mineralys Therapeutics, Inc., Tanabe Pharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 8 Years Active: 2026
Title: Robert McKean: Pharmaceutical Invention and Career
Introduction
Robert McKean is an inventor associated with Radnor, Pennsylvania, whose patent work concerns pharmaceutical compositions. His disclosed record includes 1 patent.
Latest Patents
McKean is named on the patent “Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1, 2, 4-Triazine Compound.” The invention describes pharmaceutical compositions containing a salt of a specified compound and one or more excipients. The composition is designed to avoid inducing disproportionation of the compound’s salt.
Career Highlights
McKean has been associated with Mineralys Therapeutics, Inc. and Tanabe Pharma Corporation. His patent reflects work on pharmaceutical formulation and the stability of salt-based compounds.
Collaborations
His listed coworkers include Roch Thibert and Elizabeth Vadas. Their names are associated with McKean’s professional and patent-related network.
Conclusion
Robert McKean’s recorded invention focuses on a pharmaceutical composition intended to preserve the properties of a disubstituted 1, 2, 4-triazine compound’s salt, complementing his career associations with Mineralys Therapeutics and Tanabe Pharma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile